Compare Edgewise Therapeutics Inc. Common Stock (EWTX) vs Gitlab Inc (GTLB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edgewise Therapeutics Inc. Common Stock vs Gitlab Inc — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.32 (market cap $3.94B), while Gitlab Inc trades at $52.79 (market cap $8.66B). The key difference: Gitlab Inc is far larger — about 2.2× Edgewise Therapeutics Inc. Common Stock's market cap, and Gitlab Inc is trading nearer its 52-week high, Edgewise Therapeutics Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and Gitlab Inc for 62 Days on average.
| EWTX | GTLB | |
|---|---|---|
Market Cap | $3.94B | $8.66B |
Volume | 810,104 | 9,356,692 |
Sector | Health | Technology |
52-Week High | $48.35 | $56.01 |
52-Week Low | $14.89 | $19.42 |
Typical Hold Time | 0 Days | 62 Days |
Enterprise Value | $3.48B | $7.40B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
GitLab (GTLB) trades at $53.16, down 5.09% today but remains near its 52-week high territory. The stock shows strong technical momentum with bullish moving averages despite overbought RSI readings. Fundamentally, revenue growth remains robust at 21.3% year-over-year (Q2 2026 earnings), though profitability remains elusive with negative net margins. Recent earnings beats and raised guidance have fueled positive sentiment, with the company benefiting from AI-driven demand in software development pipelines.
Outlook: GitLab's AI integration and strong execution position it for continued growth, but high valuation multiples (P/E 521) and persistent losses present risks. Analyst consensus leans Hold with $49.71 target, suggesting limited near-term upside from current levels. Key catalysts include Q3 earnings and AI product adoption, while competition and macroeconomic pressures remain headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Edgewise Therapeutics Inc. Common Stock
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →About Gitlab Inc
GitLab Inc operates on an all-remote model. The company is a technology company whose primary offering is GitLab, a complete DevOps platform delivered as a single application. GitLab is used by a wide range of organizations. The company also provides related training and professional services. GitLab is offered on both self-managed and software-as-a-service (SaaS) models. The principal markets for GitLab are currently located in the United States, Europe, and Asia Pacific. The company is focused on accelerating innovation and broadening the distribution of its platform to companies across the world.
Read more on GTLB →
